Clinical Trial: A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Observational Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands

Brief Summary:

This is a multicenter, prospective, non-interventional, observational single arm study.

Two-hundred patients will be recruited in the Netherlands over a one year period. In all cases, the decision to treat the patient with apremilast will be made prior to the decision to enter the subject into this study. Treatment will be according to routine clinical practice and based on recommendations as per the Summary of Product Characteristics (SPC) of apremilast (Otezla®). Each patient will be followed up for a maximum of 24 months.